Related Experiment Video
Updated: Jan 23, 2026
Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
Role of the DNA damage response in prostate cancer formation, progression and treatment
Wenhao Zhang1, Dik C van Gent1,2, Luca Incrocci3
1Department of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands.
Background:
Clinical and preclinical studies have revealed that alterations in DNA damage response (DDR) pathways may play an important role in prostate cancer (PCa) etiology and progression. These alterations can influence PCa responses to radiotherapy and anti-androgen treatment. The identification of DNA repair gene aberrations in PCa has driven the interest for further evaluation whether these genetic changes may serve as biomarkers for patient stratification.
Methods:
In this review, we summarize the current knowledge on DDR alterations in PCa, their potential impact on clinical interventions and prospects for improved management of PCa. We particularly focus on the influence of DDR gene mutations on PCa initiation and progression and describe the underlying mechanisms.
Results And Conclusions:
A better understanding of these mechanisms, will contribute to better disease management as treatment strategies can be chosen based on the specific disease properties, since a growing number of treatments are targeting DDR pathway alterations (such as Poly(ADP-ribose) polymerase inhibitors). Furthermore, the recently discovered crosstalk between the DDR and androgen receptor signaling opens a new array of possible strategies to optimize treatment combinations. We discuss how these recent and ongoing studies will help to improve diagnostic, prognostic and therapeutic approaches for PCa management.
Insights
Alterations in DNA damage response (DDR) pathways are key in prostate cancer (PCa) development and treatment response. Understanding these DDR gene changes can improve PCa patient stratification and management.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- DNA damage response (DDR) pathway alterations are implicated in prostate cancer (PCa) initiation and progression.
- These DDR alterations can affect patient responses to radiotherapy and anti-androgen therapies.
- Aberrations in DNA repair genes in PCa suggest potential as biomarkers for patient stratification.
Purpose of the Study:
- To review current knowledge on DDR alterations in PCa.
- To explore the impact of DDR gene mutations on PCa etiology and progression.
- To discuss the implications for clinical interventions and PCa management.
Main Methods:
- Comprehensive literature review of clinical and preclinical studies.
- Focus on the mechanisms underlying DDR gene mutations in PCa.
- Analysis of the interplay between DDR and androgen receptor signaling.
Main Results:
- DDR alterations significantly influence PCa development and treatment outcomes.
- Understanding DDR mechanisms aids in selecting tailored treatment strategies, including Poly(ADP-ribose) polymerase inhibitors.
- Crosstalk between DDR and androgen receptor signaling offers new therapeutic combination possibilities.
Conclusions:
- Improved understanding of DDR mechanisms enhances PCa disease management.
- Targeting DDR pathways provides novel therapeutic avenues for prostate cancer.
- Ongoing research promises advancements in diagnostic, prognostic, and therapeutic approaches for PCa.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
02:36DNA Damage Can Stall the Cell Cycle
02:36DNA Damage can Stall the Cell Cycle
02:56Treatment Resistant Cancers
02:25Overview of DNA Repair
Chemically...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...